Literature DB >> 2997548

Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium.

K M Mullane, R Kraemer, B Smith.   

Abstract

The infiltration of neutrophils into ischemic myocardium exacerbates myocardial damage upon reperfusion, whereas drugs that inhibit neutrophil activity or function reduce infarct size. Consequently, it is important to accurately assess the myocardial neutrophil content. Histologic sections and radiolabeled cells have been used, but have major limitations. We have developed a method to measure the neutrophils present in cardiac tissue by utilizing a spectrophotometric assay for the neutrophil-specific myeloperoxidase enzyme (MPO) (Bradley et al., 1982a). Coronary artery occlusion and reperfusion in the anesthetized dog induces neutrophil accumulation into the ischemic heart, which shows a linear relationship with time. An increase in activity from 0.014 +/- 0.001 units (u) MPO/100 mg tissue to 0.091 +/- 0.02 u MPO/100 mg is already apparent at the end of the 90-min occlusion period. This activity increases over 5 hr reperfusion to 0.32 +/- 0.018 u MPO/100 mg tissue. Histologic analyses confirmed the temporal association of neutrophil accumulation. Moreover, there is a correlation between infarct size and tissue MPO activity. Measuring the MPO content in preparations of canine neutrophils, which is directly correlated with cell number, allows units of MPO activity to be converted into a tissue neutrophil content. This assay is simple, sensitive, and provides a quantitative index of myocardial neutrophil accumulation that can be used to study the relationship between leukocyte infiltration and myocardial injury.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997548     DOI: 10.1016/0160-5402(85)90029-4

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  216 in total

1.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; G Calabrò; D Britti; G Mazzullo; A De Sarro; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

3.  Uric acid promotes an acute inflammatory response to sterile cell death in mice.

Authors:  Hajime Kono; Chun-Jen Chen; Fernando Ontiveros; Kenneth L Rock
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

4.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

5.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

6.  Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Rosanna Di Paola; Tiziana Genovese; Prabal K Chatterjee; Massimo Di Rosa; Achille P Caputi; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

7.  Genetic ablation of receptor for advanced glycation end products promotes functional recovery in mouse model of spinal cord injury.

Authors:  Ji-Dong Guo; Li Li; Ya-Min Shi; Hua-Dong Wang; Yan-Li Yuan; Xiu-Xiu Shi; Shu-Xun Hou
Journal:  Mol Cell Biochem       Date:  2014-02-14       Impact factor: 3.396

8.  A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5.

Authors:  Johan Duchene; Florence Lecomte; Saleh Ahmed; Cecile Cayla; Joao Pesquero; Michael Bader; Mauro Perretti; Amrita Ahluwalia
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.

Authors:  Rosanna Di Paola; Marta Menegazzi; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Martina Dal Bosco; Zhenzhen Zou; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2008-10-25       Impact factor: 17.440

10.  IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery.

Authors:  R G Holzheimer; R G Molloy; H Görlach; S Wilkert; F Hehrlein
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.